CWF19L1 is a protein involved in cell cycle control, and its activity can be modulated through various biochemical pathways. Chemical activators such as those that increase intracellular cyclic AMP (cAMP) levels are known to influence the function of CWF19L1. For example, compounds that activate adenylate cyclase lead to an elevation of cAMP, which in turn can enhance CWF19L1 activity through protein kinase A (PKA)-dependent pathways that are essential for the regulation of the cell cycle. Similarly, beta-adrenergic receptor agonists also raise cAMP levels, potentially augmenting the activity of CWF19L1 via similar cAMP-dependent signaling mechanisms. Additionally, the use of phosphodiesterase inhibitors prevents the breakdown of cAMP, sustaining its cellular concentration and thereby potentially increasing CWF19L1's role in cell cycle control.
Other signaling molecules also play a substantial role in modulating the activity of CWF19L1. Activation of protein kinase C through certain diacylglycerol analogs may increase CWF19L1 activity as part of downstream signaling involved in cell cycle progression. Calcium ionophores, which elevate intracellular calcium levels, can also activate CWF19L1 indirectly by stimulating calcineurin and other calcium-dependent kinases that are implicated in cell cycle control. Furthermore, compounds that donate nitric oxide can activate cGMP pathways, which in turn may influence CWF19L1 activity, potentially linking it to cell cycle control mechanisms that are dependent on cGMP signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels. Higher cAMP enhances CWF19L1 activity as it can influence cell cycle control through PKA-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which can modulate cell cycle progression and may increase CWF19L1 activity as part of downstream signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium, activating calcineurin and other calcium-dependent kinases that could enhance CWF19L1 function in calcium signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Beta-adrenergic receptor agonist that raises cAMP levels, potentially augmenting CWF19L1 activity via cAMP-dependent signaling pathways. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $73.00 $112.00 $367.00 | 18 | |
Nitric oxide donor that can activate cGMP pathways, potentially influencing CWF19L1 activity as it may play a role in cell cycle control mechanisms linked to cGMP. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Activates the PI3K/Akt pathway, which is involved in cell cycle regulation and could indirectly enhance CWF19L1's role in cell cycle control. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $32.00 $75.00 $118.00 | 14 | |
A sphingosine 1-phosphate receptor modulator that can influence cell cycle-related pathways, possibly leading to enhanced CWF19L1 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Phosphodiesterase inhibitor that prevents cAMP breakdown, potentially increasing CWF19L1 activity through elevated cAMP levels affecting cell cycle control. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Cell-permeable cAMP analog that activates cAMP-dependent pathways, potentially leading to increased CWF19L1 activity in cell cycle control. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, leading to activation of Wnt signaling. This can indirectly influence CWF19L1 by affecting pathways involved in cell cycle regulation. |